 | Up a level |
Alongi, Filippo; Nicosia, Luca; Ricardi, Umberto; Scorsetti, Marta; Greto, Daniela; Balermpas, Panagiotis; Lievens, Yolande; Braam, Pètra; Alicja Jereczek-Fossa, Barbara; Stellamans, Karin; Ratosa, Ivica; Simek, Inga-Malin; Peulen, Heike; Dirix, Piet; Verbeke, Luc; Ramella, Sara; Hemmatazad, Hossein; Khanfir, Kaouthar; Geets, Xavier; Jeene, Paul; ... (2024). Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort. Radiotherapy and oncology, 199, p. 110466. Elsevier 10.1016/j.radonc.2024.110466
Ost, Piet; Siva, Shankar; Brabrand, Sigmund; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Shelan, Mohamed; Conde-Moreno, Antonio; López Campos, Fernando; Papachristofilou, Alexandros; Guckenberger, Matthias; Scorsetti, Marta; Zapatero, Almudena; Villafranca Iturre, Ana-Elena; Eito, Clara; Couñago, Felipe; Muto, Paolo; Van De Voorde, Lien; ... (2024). PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. European urology oncology, 7(3), pp. 462-468. Elsevier 10.1016/j.euo.2023.09.007
Christ, Sebastian M; Alongi, Filippo; Ricardi, Umberto; Scorsetti, Marta; Livi, Lorenzo; Balermpas, Panagiotis; Lievens, Yolande; Braam, Pètra; Alicja Jereczek-Fossa, Barbara; Stellamans, Karin; Ratosa, Ivica; Widder, Joachim; Peulen, Heike; Dirix, Piet; Bral, Samuel; Ramella, Sara; Hemmatazad, Hossein; Khanfir, Kaouthar; Geets, Xavier; Jeene, Paul; ... (2024). Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 195(110235), p. 110235. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2024.110235
Dirix, Piet; Dal Pra, Alan; Khoo, Vincent; Carrie, Christian; Cozzarini, Cesare; Fonteyne, Valérie; Ghadjar, Pirus; Gomez-Iturriaga, Alfonso; Schmidt-Hegemann, Nina-Sophie; Panebianco, Valeria; Zapatero, Almudena; Bossi, Alberto; Wiegel, Thomas (2023). ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy. Clinical and translational radiation oncology, 43, p. 100684. Elsevier 10.1016/j.ctro.2023.100684
Dal Pra, Alan; Dirix, Piet; Khoo, Vincent; Carrie, Christian; Cozzarini, Cesare; Fonteyne, Valérie; Ghadjar, Pirus; Gomez-Iturriaga, Alfonso; Panebianco, Valeria; Zapatero, Almudena; Bossi, Alberto; Wiegel, Thomas (2023). ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer. Clinical and translational radiation oncology, 41(100638), p. 100638. Elsevier 10.1016/j.ctro.2023.100638
Achard, Vérane; Jaccard, Maud; Vanhoutte, Frederik; Siva, Shankar; Heikkilä, Reino; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Berghen, Charlien; Shelan, Mohamed; Conde-Moreno, Antonio; Campos, Fernando López; Papachristofilou, Alexandros; Guckenberger, Matthias; Meersschout, Sabine; Putora, Paul Martin; Zwahlen, Daniel; Couñago, Felipe; Scorsetti, Marta; ... (2022). Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 172, pp. 1-9. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2022.04.020
Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Shelan, Mohamed; Mercier, Carole; Achard, Vérane; Thon, Kristian; Stellamans, Karin; Moon, Daniel; Conde-Moreno, Antonio; Papachristofilou, Alexandros; Scorsetti, Marta; Gückenberger, Matthias; Ameye, Filip; Zapatero, Almudena; ... (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European urology focus, 7(2), pp. 241-244. Elsevier 10.1016/j.euf.2020.12.010
